US EditionPublished • loading... • Updated
Novartis and Linde vs. Glaxosmithkline and Medigene – Commented Kw 39 Peer Group Watch Pharma, Chemistry, Biotech, Medicine & Health
Summary by Boerse-social.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Read more: Novartis 0.64% ahead of Linde 0.05%, MorphoSys 0%, BASF -0.77%, Bayer -0.91%, Pfizer -1.12%, Fresenius -1.13%, Merck KGaA -1.52%, Ibu-Tec -1.6%, Amgen -1.69%, Gilead Sciences -2.31%, Valneva -2.49%, Sanofi -2.66%, BB Biotech -2.75%, Stratec Biomedical -3.09%, Merck Co. -3.62%, Lanxess -3.71%, Roche GS -4.38%, Baxter International -4.52%, Evotec -5.42%, Biogen Idec -5.66%, Epigenomics -6.99%, Sartorius -7.43%, Paion -11.35%, Medigene -…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
